Patent Assignment
Reel/Frame 062252/0663
Confirmation of Transfer of Patent Rights Through Merger
Recorded: 2022-12-30
Pages: 62
Assignor
FRED HUTCHINSON CANCER RESEARCH CENTER
Executed: 2022-03-30
Assignee
SEATTLE CANCER CARE ALLIANCE
825 EASTLAKE AVENUE EAST, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Inhibition of DUX4 Expression Using Bromodomain and Extra-Terminal Domain Protein Inhibitors (BETi)
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 18, 2014
From: SVERDRUP, FRANCIS M.
To: SAINT LOUIS UNIVERSITY
Reel/Frame 034199/0644 →
Assignment of Assignor's Interest
May 27, 2020
From: TAPSCOTT, STEPHEN J.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 052765/0292 →
Merger and Change of Name
Jun 8, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 060312/0424 →
Corrective Assignment to Correct the Erroroneously Filed Patent Number 7,776,547 Previously Recorded at Reel: 060312 Frame: 0424. Assignor(S) Hereby Confirms the Merger and Change of Name.
Sep 8, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 061432/0604 →
Merger
Dec 30, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER
To: SEATTLE CANCER CARE ALLIANCE
Reel/Frame 062254/0016 →